Stocks and Investing
Stocks and Investing
Fri, November 10, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, November 9, 2023
James Shin Initiated (ABBV) at Hold and Held Target at $150 on, Nov 9th, 2023
James Shin of Deutsche Bank, Initiated "AbbVie Inc." (ABBV) at Hold and Held Target at $150 on, Nov 9th, 2023.
James has made no other calls on ABBV in the last 4 months.
There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 1 agrees with James's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tim Lugo of "William Blair" Initiated at Hold on, Tuesday, July 25th, 2023
These are the ratings of the 5 analyists that currently disagree with James
- Carter Gould of "Barclays" Upgraded from Hold to Buy and Increased Target to $170 on, Monday, October 30th, 2023
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Monday, October 30th, 2023
- Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $177 on, Friday, September 29th, 2023
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $170 on, Friday, July 28th, 2023
- Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $167 on, Friday, July 14th, 2023
Contributing Sources